[144] Plexus Corp SEC Filing

Rhea-AI Filing Summary

Plexus Corp (PLXS) Form 144 notice shows a proposed sale of 1,576 common shares through Morgan Stanley Smith Barney on 08/25/2025 with an aggregate market value of $217,133.40. The shares were acquired as performance shares from the issuer on 02/13/2024. The filing also reports a prior sale by Angelo M. Ninivaggi of 2,058 common shares on 05/27/2025 for gross proceeds of $272,112.88. The issuer's total shares outstanding are reported as 26,986,726, and the proposed sale lists NASDAQ as the exchange. The filer certifies no undisclosed material adverse information is known.

Positive

• Full Rule 144 compliance details provided: broker, number of shares, acquisition date, and prior sales are disclosed
• Transparency on recent activity: prior sale of 2,058 shares with gross proceeds ($272,112.88) is reported

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine Rule 144 filing disclosing a small planned sale of performance shares and a recent related sale.

The notice provides clear transactional detail: acquisition date of the 1,576 shares is 02/13/2024 (performance shares), with the planned brokered sale slated for 08/25/2025 on NASDAQ. The filing quantifies shares outstanding at 26,986,726, allowing investors to gauge scale: the proposed sale is approximately 0.0058% of outstanding shares, indicating immaterial market impact at face value. The prior sale on 05/27/2025 (2,058 shares, $272,112.88) is disclosed, supporting transparency about recent insider-related dispositions. No financial results, insider relationship, or plan adoption details are provided in the form.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 requirements; document affirms absence of undisclosed material information by the seller.

The filing meets procedural expectations by naming the broker, listing acquisition type (performance shares), and stating prior sales during the past three months. The signature representation that the seller lacks undisclosed material adverse information is present, which is standard language in Form 144 submissions. The filing does not specify the seller's formal relationship to the issuer, so governance implications regarding dilution or insider timing cannot be further assessed from this document alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1576	217133.40	26986726	08/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/13/2024	Performance Shares	Issuer			1576	02/13/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ANGELO M NINIVAGGI One Plexus Way Neenah WI 54957	Common	05/27/2025	2058	272112.88

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the PLXS Form 144 propose to sell?

The notice proposes the sale of 1,576 common shares of Plexus Corp.

When is the proposed sale scheduled and through which broker?

The proposed sale is dated 08/25/2025 and names Morgan Stanley Smith Barney LLC as the broker.

How were the 1,576 shares acquired according to the filing?

The filing states the shares were acquired as performance shares from the issuer on 02/13/2024.

What recent sales by the same person are reported in the Form 144?

The filing reports a prior sale by Angelo M. Ninivaggi of 2,058 common shares on 05/27/2025 for gross proceeds of $272,112.88.

What is the aggregate market value and shares outstanding listed?

The proposed sale's aggregate market value is $217,133.40; total shares outstanding are reported as 26,986,726.